Related Experiment Video
Updated: Jun 16, 2026

An Intact Pericardium Ischemic Rodent Model
Published on: September 2, 2021
Post-COVID-19 Vaccination Myocarditis: A Histopathologic Study on a Monocentric Series of Six Cases
Hyo-Suk Ahn1,2, Yuran Ahn1,2, Jaehyuk Jang1,2
1Division of Cardiology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Insights
Post-COVID-19 vaccination myocarditis (PCVM) often shows mild inflammation on endomyocardial biopsy. Some cases may not meet Dallas criteria, indicating borderline myocarditis.
Area of Science:
- Cardiology
- Pathology
- Immunology
Background:
- Reports of myocarditis following COVID-19 vaccination (PCVM) are increasing.
- Few studies have examined endomyocardial biopsy (EMB) findings in PCVM.
Purpose of the Study:
- To describe the clinicopathologic features of PCVM.
- To analyze EMB results in patients with suspected PCVM.
Main Methods:
- Retrospective analysis of hospitalized patients at a single university hospital.
- Identification and detailed review of six PCVM cases.
- All six patients underwent endomyocardial biopsy (EMB).
Main Results:
- Six PCVM cases identified (five male, age 15-85).
- All patients exhibited cardiac dysfunction; two mild, four with dilated cardiomyopathy.
- Histopathology revealed lymphohistiocytic myocarditis in all cases.
- Two cases met CD3+ T lymphocyte criteria; four did not meet Dallas criteria.
Conclusions:
- Most PCVM cases exhibit mild histopathological inflammation.
- Some PCVM cases may be classified as borderline myocarditis, not meeting traditional diagnostic criteria.
Abstract:
Many reports on the development of myocarditis following coronavirus disease 2019 (COVID-19) vaccination (PCVM) have emerged. However, only a few case studies have investigated endomyocardial biopsy (EMB) results. This study describes the clinicopathologic features of PCVM. We surveyed all hospitalized patients in a single university hospital in Korea and identified six cases of PCVM. All six patients underwent EMB, five of whom were men aged 15-85 years. All patients developed cardiac dysfunction. Among these patients, two had mild disease without sequelae, whereas the other four had dilated cardiomyopathy with depressed cardiac function. All six cases demonstrated lymphohistiocytic myocarditis. Two of our cases fulfilled the criterion of CD3+ T lymphocytes > 7 cells/mm2 (Case nos. 3 and 6), while the remaining four cases did not fulfill the Dallas criteria. In conclusion, most PCVM cases showed mild degree inflammation histopathologically, and some cases could not fulfill the Dallas criteria and were classified as borderline myocarditis.
More Related Videos
Related Concept Videos
Myocarditis IV: Nursing Management
Myocarditis III: Medical Management
Myocarditis I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests

